Espicom market intelligence, brought to you by Business Monitor InternationalSudan & South Sudan Pharmaceuticals & Healthcare ReportSudan and South Sudan's will continue to be of least interest to foreign pharmaceutical firms in the Middle East and North Africa region as the countries are plagued by high inflation, fiscal constraints and underdeveloped non-oil economies. Political risk remains elevated as many disputes between them are still unresolved. These macroeconomic uncertainties will mean lack of focus on public healthcare provision, which further complicates the problem that the general population are unable to afford expensive pharmaceuticals. Headline Expenditure Projections: Pharmaceuticals: SDG1.49bn (US$556mn) in 2011 to SDG1.93bn (US$472mn) in 2012; 30.0% in local currency terms with a contraction of 15.1% in US dollar terms. Forecast unchanged from Q4 12. Healthcare: SDG11.01bn (US$4.12mn) in 2011 to SDG13.44bn (US$3.29bn) in 2012; +22.0% in local currency terms and -20% in US dollar terms. Forecast down slightly from Q4 12's , due to reassessment of historic values.Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Sudan
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
Sudan & South Sudan Pharmaceuticals & Healthcare Report
Sudan and South Sudan's will continue to be of least interest to foreign pharmaceutical firms in the Middle East and North Africa
region as the countries are plagued by high inflation, fiscal constraints and underdeveloped non-oil economies. Political risk remains
elevated as many disputes between them are still unresolved. These macroeconomic uncertainties will mean lack of focus on public
healthcare provision, which further complicates the problem that the general population are unable to afford expensive
pharmaceuticals.
Headline Expenditure Projections:
Pharmaceuticals: SDG1.49bn (US$556mn) in 2011 to SDG1.93bn (US$472mn) in 2012; 30.0% in local currency terms with a
contraction of 15.1% in US dollar terms. Forecast unchanged from Q4 12.
Healthcare: SDG11.01bn (US$4.12mn) in 2011 to SDG13.44bn (US$3.29bn) in 2012; +22.0% in local currency terms and -20% in
US dollar terms. Forecast down slightly from Q4 12's , due to reassessment of historic values.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
BMI Industry View 5
Pharmaceutical Risk/Reward Ratings 7
Table: Middle East and Africa - Q113 Risk-Reward Ratings Matrix 7
Sudan Languishes In MEA Risk/Reward Ratings 10
Rewards 11
Risks 11
Market Summary 12
Regulatory Regime 14
Industry Forecast Scenario 15
Assessing The Value Of Sudan And South Sudan's Pharmaceutical Market 15
Pharmaceutical Market Forecast 17
The Pharmaceutical Market: Sudan (From Slideshare) Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table: Pharmaceutical Sales Indicators, 2008-2016 19
Industry Developments 20
Healthcare Market Forecast 21
Table: Healthcare Expenditure Indicators, 2008-2016 23
Table: Healthcare Governmental Indicators, 2008-2016 24
Table: Healthcare Private Indicators, 2008-2016 25
Key Growth Factors ' Macroeconomic 25
Demographic Outlook 30
Table: Sudan's Population By Age Group, 1990-2020 ('000) 31
Table: Sudan's Population By Age Group, 1990-2020 (% of total) 32
Table: Sudan's Key Population Ratios, 1990-2020 33
Table: Sudan's Rural And Urban Population, 1990-2020 33
Glossary 34
BMI Methodology 36
How We Generate Our Pharmaceutical Industry Forecasts 36
Pharmaceuticals Business Environment Ratings 37
Risk/Reward Ratings Methodology 37
Ratings Overview 37
Table: Pharmaceutical Business Environment Indicators 38
Weighting 39
Table: Weighting Of Components 39
Sources 39
The Pharmaceutical Market: Sudan (From Slideshare) Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Sudan
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Sudan (From Slideshare) Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Sudan (From Slideshare) Page 4/4